Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopausen AMS on Instagram

Shortage of Menopause Hormone Therapy - 22 May 2020

The Therapeutic Goods Administration (TGA) has advised that there are currently and/or anticipated shortages of various doses of Estradot, Estalis Sequi and Climara patches in Australia.

Please see information here: http://apps.tga.gov.au/prod/msi/Search/Details/estradiol

Supply of Estraderm, Sandrena and Estrogel have not been affected and may be good alternatives for Estradot and Climara. If substituting Estraderm, Sandrena or Estrogel for Estalis Sequi, a progestogen will need to be added. Please see the AMS Guide to Equivalent MHT/HRT Doses to review the alternative options available.

There are also shortages of Angeliq and Duavive. Alternative options are available for these (such as Femonston-Conti, Kliovance, Estrogel Pro, Livial, Xyvion and Kliogest) so please check the AMS Guide to Equivalent MHT/HRT Doses to review alternative options.

Patients who are having issues with filling their prescription are encouraged to see their doctors to discuss alternative options.

Content created 22 May 2020 

Print Email


Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopauseAMS on Instagram